Caris Life Sciences Raises $830 Million in Growth Equity Capital to Continue to Expand its Precision Medicine Platform
Accelerates Caris’ rapid growth as the market leader reshaping precision oncology through basic science research and the application of artificial intelligence to one of the largest clinico-genomic databases
Capital raise represents one of the largest private financings in precision medicine supported by a diverse, high-quality syndicate of leading investorsContinue reading
The ASA Castle Biosciences Research Grant Melanoma was awarded to Joel Sunshine, M.D., Ph.D., Johns Hopkins School of Medicine
Rays of Hope provides an annual opportunity for survivors, their families, and caregivers to share experiences on their respective roads to recovery. This emotional connection often leads to greater insights about the invisible disability known as brain injury.Continue reading
• Etranacogene dezaparvovec (AMT-061) is an investigational gene therapy that may potentially provide people with hemophilia B with years of functional levels of Factor IX, a blood-clotting protein that prevents excessive bleeding.
• uniQure will complete the Phase 3 HOPE-B trial and scale up manufacture for initial commercial supply under an agreed plan with CSL Behring.
On May 5, 2021, Governor Ducey signed H.B. 2454, legislation which dramatically expands access to telehealth services in Arizona. The legislation—the most expansive in the country—makes telemedicine a permanent fixture of Arizona’s healthcare system.Continue reading
TRIPS Waiver, MCIT, HR3. If you are not familiar with these policy developments, you probably should be.
The United States medtech and biotech industries make a tremendous impact on people’s lives. When policy makers and Federal Agencies work together, the impact is made even greater. However, some policy decisions can have the opposite effect.
Standalone Diabetes Care business expected to leverage position as global leader in insulin delivery and expand presence in large and high-growth diabetes marketContinue reading
In the pandemic’s 17th month, we live in a world of vivid contrast between early-vaccinating countries that appear to be approaching an end to their epidemic and those falling rapidly into the abyss. Brazil and India are suffering escalating COVID caseloads exhausting health care resources. The long haul with the virus in the US and the current situation in Brazil and India have clearly underscored the importance of a strong, coordinated, and sustained public health response.